XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
6 Months Ended
Sep. 30, 2021
Stock-Based Compensation Recognized

The following table summarizes stock-based compensation expense by financial statement line item in the Company’s condensed consolidated statements of operation for each of the three and six months ended September 30, 2021 and 2020:

 

 

 

For the Three Months Ended September 30,

 

 

For the Six Months Ended September 30,

 

 

 

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

 

 

(in thousands)

 

Cost of revenue

 

$

1,300

 

 

$

923

 

 

$

2,330

 

 

$

1,627

 

Research and development

 

 

2,294

 

 

 

1,705

 

 

 

4,403

 

 

 

3,147

 

Selling, general and administrative

 

 

12,155

 

 

 

8,937

 

 

 

21,624

 

 

 

16,089

 

 

 

$

15,749

 

 

$

11,565

 

 

$

28,357

 

 

$

20,863

 

Summary of Stock Option Activity

The following table summarizes the stock option activity for the six months ended September 30, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Options

 

 

Exercise

 

 

Contractual

 

 

Value

 

 

 

(in thousands)

 

 

Price

 

 

Term (years)

 

 

(in thousands)

 

Outstanding at beginning of period

 

 

711

 

 

$

141.87

 

 

5.46

 

 

 

 

 

Granted

 

 

62

 

 

 

286.76

 

 

 

 

 

 

 

 

 

Exercised

 

 

(152

)

 

 

55.26

 

 

 

 

 

 

 

 

 

Cancelled and expired

 

 

(9

)

 

 

283.42

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

 

612

 

 

$

175.86

 

 

 

5.90

 

 

 

95,180

 

Exercisable at end of period

 

 

466

 

 

$

149.39

 

 

4.98

 

 

 

85,599

 

Options vested and expected to vest at end of period

 

 

612

 

 

$

175.86

 

 

 

5.90

 

 

 

95,180

 

 

Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted

The weighted average grant-date fair values and weighted average assumptions used in the calculation of fair value of options granted was as follows: 

 

 

 

For the Three Months Ended September 30,

 

 

For the Six Months Ended September 30,

 

 

 

 

2021

 

 

 

2020

 

 

 

2021

 

 

 

2020

 

Weighted average grant-date fair value

 

$

115.99

 

 

$

100.51

 

 

$

103.48

 

 

$

76.10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Valuation assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

0.77

%

 

 

0.30

%

 

 

0.79

%

 

 

0.31

%

Expected option life (years)

 

 

4.14

 

 

 

4.17

 

 

 

4.20

 

 

 

4.22

 

Expected volatility

 

 

44.72

%

 

 

43.50

%

 

 

44.30

%

 

 

42.82

%

Restricted Stock Units  
Summary of Restricted Stock Units Activity

 

The following table summarizes activity of restricted stock units for the six months ended September 30, 2021:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

 

 

(in thousands)

 

 

(per share)

 

Restricted stock units at beginning of period

 

 

301

 

 

$

273.57

 

Granted

 

 

156

 

 

 

288.64

 

Vested

 

 

(103

)

 

 

304.20

 

Forfeited

 

 

(19

)

 

 

270.35

 

Restricted stock units at end of period

 

 

335

 

 

$

271.32

 

 

Summary of Assumptions Used To Value Awards And Estimated Grant-Date Fair Value

The table below sets forth the assumptions used to value the awards and the estimated grant-date fair value:

 

 

 

May 2021

 

 

May  2020

 

Risk-free interest rate

 

 

0.3

%

 

 

0.2

%

Expected volatility

 

 

44.8

%

 

 

35.5

%

Dividend yield

 

 

 

 

 

 

Remaining performance period (years)

 

 

2.8

 

 

1.9 - 2.9

 

Estimated fair value per share

 

$

292.40

 

 

$347.05 - $349.28

 

Target performance (number of shares)

 

 

25,172

 

 

 

30,881